Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Pa
- This topic has 0 replies, 1 voice, and was last updated 4 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
https://clinicaltrials.gov/ct2/show/NCT03785873
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.